{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:29:14Z","timestamp":1772112554605,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[1996,2]]},"DOI":"10.1016\/s0026-0495(96)90056-6","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T09:46:44Z","timestamp":1094032004000},"page":"211-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus"],"prefix":"10.1016","volume":"45","author":[{"given":"L.","family":"\u00d8rskov","sequence":"first","affiliation":[]},{"given":"N.","family":"M\u00f8ller","sequence":"additional","affiliation":[]},{"given":"J.F.","family":"Bak","sequence":"additional","affiliation":[]},{"given":"N.","family":"P\u00f8rksen","sequence":"additional","affiliation":[]},{"given":"O.","family":"Schmitz","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0026-0495(96)90056-6_BIB1","series-title":"Pathogenesis and Treatment of NIDDM and Its Related Problems","first-page":"83","article-title":"Possible effects and mechanisms of action of IGF-I in the development of diabetic complications","author":"\u00d8rskov","year":"1994"},{"issue":"suppl 2","key":"10.1016\/S0026-0495(96)90056-6_BIB2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0026-0495(92)90028-9","article-title":"Endocrine applications of the somatostatin analogue octreotide (Sandostatin)","volume":"41","author":"Ezzat","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB3","first-page":"23","article-title":"Alterations in the growth hormone\/insulin-like growth factor I axis in human and experimental diabetes: Differences and similarities","volume":"vol 1","author":"Marshall","year":"1993"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB4","series-title":"A review of sixty-three years of medical research and a glimpse into the future?","first-page":"68","article-title":"Growth hormone and diabetes mellitus","volume":"40","author":"Sonksen","year":"1993"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0026-0495(90)90211-T","article-title":"Role of somatostatin and its analogues in the pathogenesis and treatment of diabetes mellitus","volume":"39","author":"Gerich","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB6","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0024-3205(82)90087-X","article-title":"SMS 201\u2013995: A very potent and selective octapeptide analogue of somatostatin with prolonged action","volume":"31","author":"Bauer","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jcem-63-5-1071","article-title":"Somatostatin analog SMS 201\u2013995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas","volume":"63","author":"Serrano Rios","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/jcem-68-1-63","article-title":"The effects of SMS 201\u2013995 (Sandostatin) on metabolic profiles in insulin-dependent diabetes mellitus","volume":"68","author":"Grossman","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB9","first-page":"766","article-title":"Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in type I (insulin-dependent) diabetes mellitus","volume":"122","author":"Kirkegaard","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB10","first-page":"187","article-title":"Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathy","volume":"120","author":"Hyer","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000180771","article-title":"Suppression of growth hormone and somatomedin C by long-acting somatostatin analog SMS 201\u2013995 in type I diabetes mellitus","volume":"27","author":"Plewe","year":"1987","journal-title":"Horm Res"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2337\/diab.38.6.704","article-title":"Metabolic effects of long-acting somatostatin analogue (Sandostatin) in type I diabetic patients on conventional therapy","volume":"38","author":"Osei","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00494.x","article-title":"Evidence for an independent relationship between insulin resistance and fasting HDL cholesterol, triglyceride, and insulin concentrations","volume":"231","author":"Laws","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.ATV.11.4.1068","article-title":"Asymptomatic atherosclerosis and insulin resistance","volume":"11","author":"Laakso","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM198708063170605","article-title":"Insulin resistance in essential hypertension","volume":"317","author":"Ferrannini","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jappl.1983.55.2.628","article-title":"Calculation of substrate oxidation rates in vivo from gaseous exchange","volume":"55","author":"Frayn","year":"1983","journal-title":"J Appl Physiol"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB17","first-page":"E736","article-title":"Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans","volume":"260","author":"Bak","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/219193b0","article-title":"Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone","volume":"219","author":"\u00d8rskov","year":"1968","journal-title":"Nature"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB19","unstructured":"Frystyk J, Dinesen B, \u00d8rskov H: Non-competitive time-resolved immunofluorometric assay for determination of human insulin-like growth factor I and II. Growth Reg (in press)"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB20","first-page":"141","article-title":"Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment","volume":"26","author":"Harrison","year":"1988","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB21","first-page":"E957","article-title":"Exercise-enhanced activation of glycogen synthase in human skeletal muscle","volume":"258","author":"Bak","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB22","first-page":"E660","article-title":"Glycogen synthase activation in human skeletal muscle: Effects of diet and exercise","volume":"236","author":"Kochan","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.1959.tb44923.x","article-title":"Influence of glucose loading and of injected insulin on hepatic glucose output","volume":"82","author":"Steele","year":"1959","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB24","first-page":"445","article-title":"On the hormonal regulation of carbohydrate metabolism: Studies with C14 glucose","volume":"19","author":"De Bodo","year":"1963","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB25","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2337\/diab.38.6.744","article-title":"Mechanism for the underestimation of isotopically determined glucose disposal","volume":"38","author":"Yki-Jarvinen","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/edrv-6-1-45","article-title":"Assessment of insulin sensitivity in vivo","volume":"6","author":"Bergman","year":"1985","journal-title":"Endocr Rev"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.1987.tb01156.x","article-title":"Continuous subcutaneous pump infusion of somatostatin analogue SMS 201\u2013995 versus subcutaneous injection schedule in acromegalic patients","volume":"27","author":"Christensen","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2337\/diacare.8.5.429","article-title":"Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201\u2013995) in insulin-dependent diabetes mellitus","volume":"8","author":"Spinas","year":"1985","journal-title":"Diabetes Care"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000198619","article-title":"Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man","volume":"22","author":"Johanson","year":"1981","journal-title":"Digestion"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/BF00212984","article-title":"Effect of the new somatostatin analogue SMS 201\u2013995 on exogenously used insulin","volume":"72","author":"Bayraktar","year":"1994","journal-title":"Clin Invest"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2265.1992.tb01443.x","article-title":"Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly","volume":"36","author":"Ho","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB32","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0196-9781(94)90145-7","article-title":"[13C]NMR studies of the effect of the somatostatin analogue octreotide on hepatic glycogenesis and glycogenolysis","volume":"15","author":"Ezzat","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0021-5198(19)52320-4","article-title":"Effects of somatostatin on liver glycogen and fat metabolism in vivo","volume":"34","author":"Ogihara","year":"1984","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB34","first-page":"E269","article-title":"Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action","volume":"250","author":"Hansen","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB35","series-title":"Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilisation","first-page":"663","article-title":"Effects of growth hormone on insulin action in man","volume":"31","author":"Rizza","year":"1982"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00505182","article-title":"Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man","volume":"32","author":"M\u00f8ller","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB37","series-title":"Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","first-page":"785","article-title":"The glucose fatty-acid cycle","volume":"1","author":"Randle","year":"1963"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00279918","article-title":"Production of insulin resistance by hyperinsulinaemia in man","volume":"28","author":"Rizza","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB39","first-page":"1789","article-title":"Somatostatin enhances insulin stimulated glucose uptake in the perfused human forearm","volume":"80","author":"M\u00f8ller","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB40","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2337\/diacare.31.11.957","article-title":"The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man","volume":"31","author":"Thiebaud","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2265.1986.tb03630.x","article-title":"Effects of somatostatin analogue SMS 201\u2013995 in non-insulin-dependent diabetes","volume":"25","author":"Davies","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/00365528609087445","article-title":"Effects of somatostatin and SMS 201\u2013995 on carbohydrate metabolism in normal man","volume":"119","author":"Johnston","year":"1986","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB43","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1146\/annurev.bi.44.070175.004441","article-title":"Amino acid metabolism in man","volume":"44","author":"Felig","year":"1975","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB44","first-page":"103","article-title":"The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis","volume":"119","author":"Wahren","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0261-5614(94)90068-X","article-title":"Effect of lanreotide, a somatostatin analog, on urea synthesis in normal man","volume":"13","author":"Wolthers","year":"1994","journal-title":"Clin Nutr"},{"key":"10.1016\/S0026-0495(96)90056-6_BIB46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-2007-1010938","article-title":"Severe hypoglycemia as a short-term side-effect of the somatostatin analog SMS 201\u2013995 in insulin-dependent diabetes mellitus","volume":"20","author":"Navascues","year":"1988","journal-title":"Horm Metab Res"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049596900566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049596900566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T02:37:01Z","timestamp":1758422221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049596900566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["S0026049596900566"],"URL":"https:\/\/doi.org\/10.1016\/s0026-0495(96)90056-6","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[1996,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0026-0495(96)90056-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}